This condition is a common side effect of chemotherapy. Severe myelosuppression, called myeloablation, can be fatal. The body’s bone marrow produces three types of cells: white blood cells, red blood cells, and platelets. Chloroquine effets secondaires Plaquenil ear problems Low Blood Counts Due To Bone Marrow Failure; Low Blood Sugar; Low Levels Of A Type Of White Blood Cell Called Neutrophils; Low Levels Of White Blood Cells; Maculopathy; Mental Problems From Taking. Bone marrow suppression is a common dose-limiting toxicity for most immunosuppressive drugs, apart from hydroxychloroquine and the glucocorticoids. The recommendations for monitoring are largely based on expert consensus and often differ slightly. 1, 2 Table 1 has a suggested frequency of monitoring for patients who have been stable on maintenance doses of immunosuppressive drugs. Hydroxychloroquine HCQ is a disease-modifying anti-rheumatic drug DMARD typically used for the treatment of various rheumatic and dermatologic diseases. Three studies of HCQ in OA, including one abstract and one letter, are available and use a wide variety of outcome measures in small patient populations. A decrease in all three types of blood cells is referred to as pancytopenia. It can cause an oxygen shortage and other immune issues. Myelosuppression can decrease some or all of these. Hydroxychloroquine bone marrow suppression Drugs that Cause Bone Marrow Depression -, Long-term management of patients taking immunosuppressive drugs Hydroxychloroquine and l lysinePlaquenil for arthritis painPlaquenil hyperpigmentationPlaquenil with celebrexHow much is hydroxychloroquine without insurance at cvs Bone marrow suppression is rare, but potentially fatal agranulocytosis or aplastic anaemia can occur. Monitoring the blood count is not generally considered necessary. Much attention has been given to the corneal and retinal damage that may occur following treatment with anti-malarials. Disease-modifying Anti-rheumatic Drugs DMARDs for.. Hydroxychloroquine in patients with inflammatory and.. HYDROXYCHLOROQUINE. Bone marrow suppression refers to a decrease in the ability of the bone marrow to manufacture cells, and is common with chemotherapy. In addition to eliminating cancer cells, chemotherapy drugs eliminate normal cells that divide rapidly, such as those in the bone marrow that form the different types of blood cells. Hydroxychloroquine has also been reported to cause severe hypoglycemia in some patients with diabetes who are also taking hypoglycemic drugs and rarely to cause bone marrow suppression. 8. References. Plaquenil package insert. St Michael, Barbados, BBI Concordia Pharmaceuticals, Inc; 2017. Plaquenil Hydroxychloroquine package insert. It commonly causes gastrointestinal disturbances and less commonly retinal toxicity, itching, intravascular hemolysis, rashes, and bone marrow suppression. Musculoskeletal Muscle and peripheral nerve toxicity is rare with hydroxychloroquine.